Nutrition and Food Research Center (NuFo)

  

  

  

1 of 2

  

  

  

---

• Alanne, Soili
• Bekele, Helen
• Haataja, Kira
• Hieta, Janina
• Hopia, Anu
• Houttu, Noora
• Houttu, Veera
• Jakonen, Mitja
• Jylhä, Aino
• Kaya Kacar, Hüsna
• Kerttula, Anni
• Koivuniemi, Ella
• Koskimäki, Sanna
• Lähde, Hanna
• Laikola, Sini
• Lehtinen, Maarit
• Lepistö, Leo
• Logren, Nora
• Mattila, Saila
• Mokkala, Kati

  

  

  

79 of 110

  

  

  

---

• Scientific Opinion on the substantiation of health claims related to fructooligosaccharides (FOS) from sucrose and decreasing potentially pathogenic gastro intestinal microorganisms (ID 774), changes in short chain fatty acid (SCFA) production and pH in the gastro-intestinal tract (ID 775), changes in bowel function (ID 775, 778), reduction of gastro intestinal discomfort (ID 775, 778), increase in calcium and/or magnesium absorption leading to an increase in magnesium and/or calcium retention (ID 776, 777), maintenance of normal blood LDL cholesterol concentrations (ID 805) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 805) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
• Scientific Opinion on the substantiation of health claims related to fructose and reduction of post-prandial glycaemic responses (ID 558) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
• Scientific Opinion on the substantiation of health claims related to fruits and/or vegetables (ID 1212, 1213, 1214, 1217, 1218, 1219, 1301, 1425, 1426, 1427, 1428, 1429, 1430) and to the “Mediterranean diet” (ID 1423) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
• Scientific Opinion on the substantiation of health claims related to galacto oligosaccharides (GOS) and reduction of gastro intestinal discomfort (ID 763) and decreasing potentially pathogenic microorganisms (ID 765) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
• Scientific Opinion on the substantiation of health claims related to gamma linolenic acid and maintenance of joints (ID 494, 637, 1774, 2098), weight maintenance following weight loss (ID 496), maintenance of peripheral blood flow (ID 638), maintenance of normal blood pressure (ID 1771), maintenance of normal blood cholesterol concentrations (ID 1771) and maintenance of bone (ID 1774) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2010)
• Scientific Opinion on the substantiation of health claims related to gamma linolenic acid (GLA) and maintenance of normal blood LDL cholesterol concentrations (ID 2661, 4452, 4453), maintenance of normal blood pressure (ID 2662), reduction of menstrual discomfort (ID 495, 640, 1773, 1775), contribution to normal cognitive function (ID 1770), maintenance of the barrier function of the skin (ID 499, 591, 639, 676, 1554, 2003, 2065), “function of the cell membrane” (ID 1769), maintenance of normal structure, elasticity and appearance of the skin (ID 2660, 4296), and “anti-inflammatory properties” (ID 4454) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
• Scientific Opinion on the substantiation of health claims related to glycaemic carbohydrates and maintenance of normal brain function (ID 603, 653) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
• Scientific Opinion on the substantiation of health claims related to guar gum and maintenance of normal blood glucose concentrations (ID 794), increase in satiety (ID 795) and maintenance of normal blood cholesterol concentrations (ID 808) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2010)
• "Scientific Opinion on the substantiation of health claims related to honey and ""respiratory health through presence of antioxidant phytochemicals"" (ID 1161), ""the unique composition and ratio of effective substances adds energy to the human body"" (ID 3188), and ""it stimulates the whole metabolism and the immune system"" (ID 3189) pursuant to Article 13(1) of Regulation (EC) No 1924/2006"  (2010)
• Scientific Opinion on the substantiation of health claims related to hydroxypropyl methylcellulose (HPMC) and maintenance of normal bowel function (ID 812), reduction of post-prandial glycaemic responses (ID 814), maintenance of normal blood cholesterol concentrations (ID 815) and increase in satiety leading to a reduction in energy intake (ID 2933) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2010)